Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis

Corrado Tamburino; Davide Capodanno; Angelo Ramondo; Anna Sonia Petronio; Federica Ettori; Gennaro Santoro; Silvio Klugmann; Francesco Bedogni; Francesco Maisano; Antonio Marzocchi; Arnaldo Poli; David Antoniucci; Massimo Napodano; Marco De Carlo; Claudia Fiorina; Gian Paolo Ussia

doi:10.1161/CIRCULATIONAHA.110.946533

Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis

Corrado Tamburino, Davide Capodanno, Angelo Ramondo, Anna Sonia Petronio, Federica Ettori, Gennaro Santoro, Silvio Klugmann, Francesco Bedogni, Francesco Maisano, Antonio Marzocchi, Arnaldo Poli, David Antoniucci, Massimo Napodano, Marco De Carlo, Claudia Fiorina, Gian Paolo Ussia

IRCCS Policlinico San Donato

Research output: Contribution to journal › Article › peer-review

Abstract

Background- There is a lack of information on the incidence and predictors of early mortality at 30 days and late mortality between 30 days and 1 year after transcatheter aortic valve implantation (TAVI) with the self-expanding CoreValve Revalving prosthesis. Methods and Results- A total of 663 consecutive patients (mean age 81.0±7.3 years) underwent TAVI with the third generation 18-Fr CoreValve device in 14 centers. Procedural success and intraprocedural mortality were 98% and 0.9%, respectively. The cumulative incidences of mortality were 5.4% at 30 days, 12.2% at 6 months, and 15.0% at 1 year. The incidence density of mortality was 12.3 per 100 person-year of observation. Clinical and hemodynamic benefits observed acutely after TAVI were sustained at 1 year. Paravalvular leakages were trace to mild in the majority of cases. Conversion to open heart surgery (odds ratio [OR] 38.68), cardiac tamponade (OR 10.97), major access site complications (OR 8.47), left ventricular ejection fraction

Original language	English
Pages (from-to)	299-308
Number of pages	10
Journal	Circulation
Volume	123
Issue number	3
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.110.946533
Publication status	Published - Jan 25 2011

Keywords

aortic stenosis
aortic valve
transcatheter aortic valve implantation
valve prosthesis

ASJC Scopus subject areas

Physiology (medical)
Cardiology and Cardiovascular Medicine

Access to Document

10.1161/CIRCULATIONAHA.110.946533

Fingerprint Dive into the research topics of 'Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis'. Together they form a unique fingerprint.

Cite this

Tamburino, C., Capodanno, D., Ramondo, A., Petronio, A. S., Ettori, F., Santoro, G., Klugmann, S., Bedogni, F., Maisano, F., Marzocchi, A., Poli, A., Antoniucci, D., Napodano, M., De Carlo, M., Fiorina, C., & Ussia, G. P. (2011). Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation, 123(3), 299-308. https://doi.org/10.1161/CIRCULATIONAHA.110.946533

Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. / Tamburino, Corrado; Capodanno, Davide; Ramondo, Angelo; Petronio, Anna Sonia; Ettori, Federica; Santoro, Gennaro; Klugmann, Silvio; Bedogni, Francesco; Maisano, Francesco; Marzocchi, Antonio; Poli, Arnaldo; Antoniucci, David; Napodano, Massimo; De Carlo, Marco; Fiorina, Claudia; Ussia, Gian Paolo.

In: Circulation, Vol. 123, No. 3, 25.01.2011, p. 299-308.

Research output: Contribution to journal › Article › peer-review

Tamburino, C, Capodanno, D, Ramondo, A, Petronio, AS, Ettori, F, Santoro, G, Klugmann, S, Bedogni, F, Maisano, F, Marzocchi, A, Poli, A, Antoniucci, D, Napodano, M, De Carlo, M, Fiorina, C & Ussia, GP 2011, 'Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis', Circulation, vol. 123, no. 3, pp. 299-308. https://doi.org/10.1161/CIRCULATIONAHA.110.946533

Tamburino, Corrado ; Capodanno, Davide ; Ramondo, Angelo ; Petronio, Anna Sonia ; Ettori, Federica ; Santoro, Gennaro ; Klugmann, Silvio ; Bedogni, Francesco ; Maisano, Francesco ; Marzocchi, Antonio ; Poli, Arnaldo ; Antoniucci, David ; Napodano, Massimo ; De Carlo, Marco ; Fiorina, Claudia ; Ussia, Gian Paolo. / Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. In: Circulation. 2011 ; Vol. 123, No. 3. pp. 299-308.

@article{a59c5e0834284bf782a22cfdeded4e9c,

title = "Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis",

abstract = "Background- There is a lack of information on the incidence and predictors of early mortality at 30 days and late mortality between 30 days and 1 year after transcatheter aortic valve implantation (TAVI) with the self-expanding CoreValve Revalving prosthesis. Methods and Results- A total of 663 consecutive patients (mean age 81.0±7.3 years) underwent TAVI with the third generation 18-Fr CoreValve device in 14 centers. Procedural success and intraprocedural mortality were 98% and 0.9%, respectively. The cumulative incidences of mortality were 5.4% at 30 days, 12.2% at 6 months, and 15.0% at 1 year. The incidence density of mortality was 12.3 per 100 person-year of observation. Clinical and hemodynamic benefits observed acutely after TAVI were sustained at 1 year. Paravalvular leakages were trace to mild in the majority of cases. Conversion to open heart surgery (odds ratio [OR] 38.68), cardiac tamponade (OR 10.97), major access site complications (OR 8.47), left ventricular ejection fraction ",

keywords = "aortic stenosis, aortic valve, transcatheter aortic valve implantation, valve prosthesis",

author = "Corrado Tamburino and Davide Capodanno and Angelo Ramondo and Petronio, {Anna Sonia} and Federica Ettori and Gennaro Santoro and Silvio Klugmann and Francesco Bedogni and Francesco Maisano and Antonio Marzocchi and Arnaldo Poli and David Antoniucci and Massimo Napodano and {De Carlo}, Marco and Claudia Fiorina and Ussia, {Gian Paolo}",

year = "2011",

month = jan,

day = "25",

doi = "10.1161/CIRCULATIONAHA.110.946533",

language = "English",

volume = "123",

pages = "299--308",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins",

number = "3",

}

TY - JOUR

T1 - Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis

AU - Tamburino, Corrado

AU - Capodanno, Davide

AU - Ramondo, Angelo

AU - Petronio, Anna Sonia

AU - Ettori, Federica

AU - Santoro, Gennaro

AU - Klugmann, Silvio

AU - Bedogni, Francesco

AU - Maisano, Francesco

AU - Marzocchi, Antonio

AU - Poli, Arnaldo

AU - Antoniucci, David

AU - Napodano, Massimo

AU - De Carlo, Marco

AU - Fiorina, Claudia

AU - Ussia, Gian Paolo

PY - 2011/1/25

Y1 - 2011/1/25

N2 - Background- There is a lack of information on the incidence and predictors of early mortality at 30 days and late mortality between 30 days and 1 year after transcatheter aortic valve implantation (TAVI) with the self-expanding CoreValve Revalving prosthesis. Methods and Results- A total of 663 consecutive patients (mean age 81.0±7.3 years) underwent TAVI with the third generation 18-Fr CoreValve device in 14 centers. Procedural success and intraprocedural mortality were 98% and 0.9%, respectively. The cumulative incidences of mortality were 5.4% at 30 days, 12.2% at 6 months, and 15.0% at 1 year. The incidence density of mortality was 12.3 per 100 person-year of observation. Clinical and hemodynamic benefits observed acutely after TAVI were sustained at 1 year. Paravalvular leakages were trace to mild in the majority of cases. Conversion to open heart surgery (odds ratio [OR] 38.68), cardiac tamponade (OR 10.97), major access site complications (OR 8.47), left ventricular ejection fraction

AB - Background- There is a lack of information on the incidence and predictors of early mortality at 30 days and late mortality between 30 days and 1 year after transcatheter aortic valve implantation (TAVI) with the self-expanding CoreValve Revalving prosthesis. Methods and Results- A total of 663 consecutive patients (mean age 81.0±7.3 years) underwent TAVI with the third generation 18-Fr CoreValve device in 14 centers. Procedural success and intraprocedural mortality were 98% and 0.9%, respectively. The cumulative incidences of mortality were 5.4% at 30 days, 12.2% at 6 months, and 15.0% at 1 year. The incidence density of mortality was 12.3 per 100 person-year of observation. Clinical and hemodynamic benefits observed acutely after TAVI were sustained at 1 year. Paravalvular leakages were trace to mild in the majority of cases. Conversion to open heart surgery (odds ratio [OR] 38.68), cardiac tamponade (OR 10.97), major access site complications (OR 8.47), left ventricular ejection fraction

KW - aortic stenosis

KW - aortic valve

KW - transcatheter aortic valve implantation

KW - valve prosthesis

UR - http://www.scopus.com/inward/record.url?scp=79251565276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79251565276&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.110.946533

DO - 10.1161/CIRCULATIONAHA.110.946533

M3 - Article

C2 - 21220731

AN - SCOPUS:79251565276

VL - 123

SP - 299

EP - 308

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 3

ER -